Search Results 31-40 of 16322 for immunothérapie Bylaska
Clinical Trials · Spatial and Molecular Architecture of Tumor Environments Responsive to IO (immuno-oncology) Therapy · More about research at Mayo Clinic · Mayo ...
In a 2022 study, Mayo Clinic researchers found that by transfecting cytotoxic CD8+ T cells with mRNA of natural killer cells they can improve response in ...
These include targeted therapy, immunotherapy, CAR-T cell therapy, stem cell transplant and clinical trials. Your care team works with you to understand ...
The David F. and Margaret T. Grohne Cancer Immunology and Immunotherapeutics Research Program of Mayo Clinic Comprehensive Cancer Center conducts research ...
The following tumor types are included in this study: Non-Small Cell Lung Cancer (NSCLC), gastric cancer, hepatocellular carcinoma, renal cell carcinoma, ...
To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...
Pembrolizumab injection is used alone to treat non-small cell lung cancer (NSCLC) that has spread, whose tumors express PD-L1 and do not have an abnormal EGFR ...
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove ...
Using a mouse model of the blood cancer multiple myeloma, scientists at Mayo Clinic in Arizona are once again providing insight that could improve care for ...
Cancer is caused by changes (mutations) to genes that control the way cells function. Tumors with high number of mutations may respond well to immunotherapy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.